Written by internationally renowned experts, the 3rd edition of this six volume textbook provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book is divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, Orbital Tumors, Uveal Tumors, Retinal Tumors, and Retinoblastoma. The information presented enables readers to provide effective patient care using the latest knowledge on ophthalmic oncology and to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations. 

Clinical Ophthalmic Oncology's clinically focused and user-friendly format allows for rapid retrieval of information in daily practice and is written for residents, fellows, and any physician involved in the care of patients with ocular or orbital malignancies. Additionally, this edition adds several hundred new images to improve comprehension of procedures and techniques. This volume describes the classification, differential diagnosis, and imaging of retinoblastoma and discusses the most suitable treatment options for different tumor types.?

Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center and then completed a fellowship in Ocular Oncology at Children's Hospital Los Angeles. Dr. Berry is the founder of WOO, Women in Ocular Oncology.

Jonathan Kim, MD, is Director of the Retinoblastoma Program, Attending Physician, and Associate Professor of Clinical Surgery at the Keck School of Medicine of USC. Dr. Kim provides clinical expertise in the management of pediatric intraocular tumors. He was trained at Memorial Sloan-Kettering Cancer Center, Jules Stein Eye Institute at UCLA, and the Massachusetts Eye and Ear Infirmary at Harvard Medical School. He is developing new treatment modalities to save the eyes of children with retinoblastoma and is actively engaged in new research projects. 

Jesse L. Berry, MD

Assistant Professor of Clinical Ophthalmology

USC Roski Eye Institute

Children's Hospital Los Angeles  

Keck School of Medicine of USC

California, USA

Jonathan W. Kim, MD

Director of Retinoblastoma Program, Children's Hospital Los Angeles

Associate Professor of Clinical Ophthalmology

Department of Ophthalmology 

USC Roski Eye Institute

Keck School of Medicine of USC

1975 Zonal Ave, Los Angeles

California, USA

Bertil E. Damato, MD, PhD

Professor of Ophthalmology and Radiation Oncology

University of Oxford

Nuffield Department of Clinical Neurosciences

John Radcliffe Hospital

Oxford, UK?

Arun D. Singh, MD

Professor of Ophthalmology

Editor, Ocular Oncology and Pathology

Director, Dept. of Ophthalmic Oncology

Cole Eye Institute, Cleveland Clinic

9500 Euclid Avenue, Cleveland

Ohio, USA